2013

Klaren WD, Lai IK, Robertson LW. Search for the basis of PCB126-triggered disruption of hepatic metal homeostasis in rodents. Society of Toxicology Annual Meeting, San Antonio, Tx, 2013.

Klaren WD, Robertson LW. PCB126 induced increases in metallothionein expression may be species specific and AhR dependent. Society of Toxicology, Central States Regional Chapter Annual Meeting, Ames, Ia, 2013.

Klaren WD, Robertson LW. Increases in metallothionein expression caused by PCB126 are linked to species sensitivity and are potentially mediated through the AhR. Superfund Annual Meeting, Baton Rouge, La, 2013.

Lai IK*, Klaren WD*, Li M, Wels B, Simmons DL, Olivier AK, Haschek WM, Wang K, Ludewig G, and Robertson LW. 2013. Does dietary copper supplementation enhance or diminish PCB126 toxicity in the rodent liver?  Chem Res Toxicol 26(5):634–644 (*Co-First Authors), PMID: 23527585.

View Abstract

2012

Wang B, Wels BR, Klaren WD, Wang K, Robertson LW, Ludewig G. Regulation of MnSOD by the AhR agonist PCB126: The role of dietary manganese. Society of Toxicology Annual Meeting, San Francisco, Ca, 2012. Also presented at Superfund Annual Meeting, Lexington, Ky, 2012.

View Abstract

Klaren WD, Lai IK, Robertson LW. Search for the basis of PCB-triggered disruption in hepatic copper in rodents. Best Poster Award, University of Iowa Research Week, Iowa City, Ia, 2012.

Klaren WD, Lai IK, Robertson LW. Search for the basis of PCB126-triggered disruption of hepatic metal homeostasis in rats. Superfund Annual Meeting, Raleigh, NC, 2012. Also given at the Society of Toxicology, Central States Regional Chapter Annual Meeting, Manhattan, KS, 2012.

Lynch M, Brown L, Chun A, Reid J, Russel P. Risk communication for the Toxic Release Inventory. Poster presentation to Society for Risk Analysis, 2012.

Henderson RG, Durando J, Oller A, Merkel DJ, Marone PA,  Bates HK. 2012. Acute oral toxicity of nickel compounds. Regul Toxicol Pharmacol 62(3):425-432.

View Abstract

2010

Waters MD, Jackson MA, Lea IA. 2010. Characterizing and predicting carcinogenicity and mode-of-action using conventional and toxicogenomics methods. Mutat Res 705(3):184–200.

View Abstract